Corporate Governance

At Vivoryon Therapeutics we believe the essence of good corporate governance is efficient cooperation between all employees and our Board members, respect for the shareholders’ interests, and transparent corporate communications. As such, strong corporate governance is an integral part of our corporate value system and we are convinced that adherence to high governance standards will ultimately increase shareholder value.

Articles of Association

.

Code of Conduct.

.

Corporate Governance Report (as part of the Annual Report)

.

Competence Profile and Board Rules

Board profile

Board rules

Board retirement schedule

Audit committee rules

Compensation Committee Rules

Nomination and Corporate Governance Committee Rules

Investor Relations Committee Rules

Committee Composition

*Name*	*Audit Committee*	*Compensation Committee*	*Nomination and Corporate* *Governance Committee*	*Investor Relations* *Committee*
Erich Platzer, MD, PhD (Chairman of the Board)		M	M	M
Kugan Sathiyanandarajah; FE (Vice-Chairman of the Board)	M	C
Professor Morten Asser Karsdal MSc, PhD, mMBA			M	M
Charlotte Lohmann	M	M	C
Claudia Riedl, PhD	C
Samir Shah, MD				C
C: Chair; M: Member; FE: Financial Expert